Gene Expression Profile Analysis for Tissue Classification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing microarray gene expression data, particularly in cancer diagnostics, struggle to compare single samples against reference databases effectively, often requiring predefined gene sets and control groups, which limits their ability to provide comprehensive and accurate interpretations, especially for personalized diseases like cancer where each case can have unique genetic mutations.

Innovation Solution

The Alignment of Gene Expression Profiles (AGEP) method, which calculates expression match scores and tissue specificity scores to compare a query sample against a large reference database, allowing for the identification of tissue categories and genes that define similarities without prior assumptions, enabling diagnosis and treatment recommendations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If case-control study design is used to analyze microarray data, then statistically significant interpretation of differentially expressed genes is achieved, but interpretation of data from individual samples becomes impossible

Engineering Contradiction:
Improvestatistical significanceVSAvoidindividual sample interpretation
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The invention segments the reference database into multiple tissue categories with distinct gene expression profiles. Each category is characterized by a set of marker genes that define its biological identity. This segmentation allows individual samples to be compared against specific tissue categories rather than requiring large case-control groups, enabling both statistical reliability and individual sample interpretation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces tissue category profiles as intermediary references between individual samples and known biological states. These profiles serve as mediators that enable comparison of single samples against comprehensive reference databases, allowing interpretation without requiring matched control samples for each individual case.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If predefined gene sets and control groups are used, then analysis framework is established, but ability to handle unique genetic mutations in personalized diseases is limited

Engineering Contradiction:
Improveanalysis frameworkVSAvoidpersonalized disease analysis
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The invention dynamically adapts the reference framework by allowing individual samples to define their own characteristic gene expression profiles. Rather than forcing samples into predefined categories, the system enables samples to be compared against multiple tissue categories simultaneously, revealing unique patterns that may indicate personalized disease states or novel tissue types.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The invention creates a universal reference framework where the same tissue category profiles can be applied across different diseases and sample types. The marker gene sets and comparison methods are universally applicable, allowing the system to handle both well-known diseases and previously uncharacterized conditions using the same analytical approach.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Quantity of substance

If large-scale databases from publicly available microarray datasets are used, then comprehensive reference samples are available, but no tools are available for comparing single samples against these databases

Engineering Contradiction:
Improvereference sample availabilityVSAvoidsingle sample comparison capability
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The invention performs preliminary organization of the reference database by pre-calculating and storing tissue category profiles, marker gene sets, and expression level thresholds. This preliminary processing transforms the raw comprehensive database into a structured format that enables straightforward single-sample comparison, making the large-scale reference accessible and easy to use without requiring complex real-time analysis.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentEP2545481B1A method, an arrangement and a computer program product for analysing a biological or medical sample
Publication Date: 2020.02.19 MEDISAPIENS OY
  • EP2545481B1 patent drawingFigure 1a
  • EP2545481B1 patent drawingFigure 1b
  • EP2545481B1 patent drawingFigure 2a

AI summary

An aspect of the present invention is a computer executable method for characterizing, e.g. for diagnostic purposes, utilizing a reference database, a query sample tissue based on the gene expression data of the tissue. The method is characterized in that it comprises the steps of calculating an expression match score (EM-score) indicating the likelihood of having the gene expression level observed in the query sample in each of the tissue categories of the reference database, calculating for the genes of the sample tissue, using e.g. the EM- score, tissue specificity score (TS-score), that expresses how uniquely a gene identifies the query sample as belonging to a certain tissue category, calculating, utilizing e.g. the TS- score, overall similarity of the sample tissue in relation to a tissue category of the reference database, and storing at least some resulting characterization data to a memory device or outputting the data to an output device of a computer. An arrangement and a computer program product are also disclosed.